Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

Sitagliptin added to treatment with ongoing pioglitazone for up to 52 weeks improves glycemic control in Japanese patients with type 2 diabetes.

Kashiwagi A, Kadowaki T, Tajima N, Nonaka K, Taniguchi T, Nishii M, Ferreira JC, Amatruda JM.

J Diabetes Investig. 2011 Oct 7;2(5):381-90. doi: 10.1111/j.2040-1124.2011.00120.x.

PMID:
24843518
[PubMed]
Free PMC Article
2.

Effects of replacing metformin with pioglitazone on glycemic control in japanese patients with poorly controlled type 2 diabetes mellitus: A 12-week, open-label, prospective study.

Sakaue S, Kamigaki M, Yoshimura H, Nishimura M.

Curr Ther Res Clin Exp. 2008 Aug;69(4):364-77. doi: 10.1016/j.curtheres.2008.08.005.

PMID:
24692813
[PubMed]
Free PMC Article
3.

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated.

Irons BK, Minze MG.

Diabetes Metab Syndr Obes. 2014 Jan 18;7:15-24. doi: 10.2147/DMSO.S38753. eCollection 2014 Jan 18. Review.

PMID:
24465132
[PubMed]
Free PMC Article
4.

Chinese herbal medicine for impaired glucose tolerance: a randomized placebo controlled trial.

Grant SJ, Chang DH, Liu J, Wong V, Kiat H, Bensoussan A.

BMC Complement Altern Med. 2013 May 14;13(1):104. doi: 10.1186/1472-6882-13-104.

PMID:
23672597
[PubMed - in process]
Free PMC Article
5.

Metformin and its clinical use: new insights for an old drug in clinical practice.

Cicero AF, Tartagni E, Ertek S.

Arch Med Sci. 2012 Nov 9;8(5):907-17. doi: 10.5114/aoms.2012.31622. Epub 2012 Nov 7.

PMID:
23185203
[PubMed]
Free PMC Article
6.

PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty.

Huang JV, Greyson CR, Schwartz GG.

J Lipid Res. 2012 Sep;53(9):1738-54. doi: 10.1194/jlr.R024505. Epub 2012 Jun 8. Review.

PMID:
22685322
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study.

Russell-Jones D, Cuddihy RM, Hanefeld M, Kumar A, González JG, Chan M, Wolka AM, Boardman MK; DURATION-4 Study Group.

Diabetes Care. 2012 Feb;35(2):252-8. doi: 10.2337/dc11-1107. Epub 2011 Dec 30.

PMID:
22210563
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Risk management in the treatment of type 2 diabetes with pioglitazone.

Derosa G, Salvadeo SA.

Diabetes Metab Syndr Obes. 2009 Jul 1;2:51-60.

PMID:
21437118
[PubMed]
Free PMC Article
9.

Treatment with sitagliptin or metformin does not increase body weight despite predicted reductions in urinary glucose excretion.

Waters SB, Topp BG, Siler SQ, Alexander CM.

J Diabetes Sci Technol. 2009 Jan;3(1):68-82.

PMID:
20046651
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders.

Heal DJ, Gosden J, Smith SL.

Br J Clin Pharmacol. 2009 Dec;68(6):861-74. doi: 10.1111/j.1365-2125.2009.03549.x.

PMID:
20002080
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Redefining the role of thiazolidinediones in the management of type 2 diabetes.

Barnett AH.

Vasc Health Risk Manag. 2009;5(1):141-51. Epub 2009 Apr 8. Review.

PMID:
19436665
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Performing meta-analysis with incomplete statistical information in clinical trials.

Ma J, Liu W, Hunter A, Zhang W.

BMC Med Res Methodol. 2008 Aug 18;8:56. doi: 10.1186/1471-2288-8-56.

PMID:
18706124
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

A review of pioglitazone HCL and glimepiride in the treatment of type 2 diabetes.

Dorkhan M, Frid A.

Vasc Health Risk Manag. 2007;3(5):721-31. Review.

PMID:
18078023
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive study.

Erdmann E, Dormandy J, Wilcox R, Massi-Benedetti M, Charbonnel B.

Vasc Health Risk Manag. 2007;3(4):355-70. Review.

PMID:
17969365
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Management of type 2 diabetes mellitus. Role of thiazolidinediones.

Noble J, Baerlocher MO, Silverberg J.

Can Fam Physician. 2005 May;51:683-7. Review.

PMID:
15934272
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Medicaid managed care: disparities in the use of thiazolidinediones compared with metformin.

Shaya FT, Shin JY, Mullins D, Fatodu HO, Gu A, Saunders E.

J Natl Med Assoc. 2005 Apr;97(4):493-7.

PMID:
15868769
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats.

Yang B, Brown KK, Chen L, Carrick KM, Clifton LG, McNulty JA, Winegar DA, Strum JC, Stimpson SA, Pahel GL.

BMC Pharmacol. 2004 Oct 18;4:23.

PMID:
15491498
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk